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ABSTRACT
LINE-1 expression damages host DNA via insertions
and endonuclease-dependent DNA double-strand
breaks (DSBs) that are highly toxic and mutagenic.
The predominant tissue of LINE-1 expression has
been considered to be the germ line. We show that
both full-length and processed L1 transcripts are
widespread in human somatic tissues and trans-
formed cells, with significant variation in both L1
expression and L1 mRNA processing. This is the
first demonstration that RNA processing is a major
regulator of L1 activity. Many tissues also produce
translatable spliced transcript (SpORF2). An Alu
retrotransposition assay, COMET assays and
53BP1 foci staining show that the SpORF2 product
can support functional ORF2 protein expression and
can induce DNA damage in normal cells. Tests
of the senescence-associated b-galactosidase
expression suggest that expression of exogenous
full-length L1, or the SpORF2 mRNA alone in
human fibroblasts and adult stem cells triggers a
senescence-like phenotype, which is one of the
reported responses to DNA damage. In contrast to
previous assumptions that L1 expression is germ
line specific, the increased spectrum of tissues
exposed to L1-associated damage suggests a
role for L1 as an endogenous mutagen in somatic
tissues. These findings have potential conse-
quences for the whole organism in the form of
cancer and mammalian aging.
INTRODUCTION
Long interspersed element-1, LINE-1 or L1, is an auton-
omous family of retroelements that is currently active in
mammalian genomes (1). The human genome has
accumulated about 500000 L1 copies, amounting to
17% of genomic content (2). The majority of L1 inserts
are 50-truncated or rearranged (2); and as a result they are
retrotranspositionally inactive. Approximately 3000 L1s
in the human genome are full-length (i.e. they contain
50- and 30-UTRs and sequences in between without
major rearrangement), with about 150 containing both
intact open reading frames (ORF) 1 and 2, and about
100 additional elements maintaining only intact ORF2
(3). Both ORFs are required for L1 retrotransposition in
cultured cells (4).
L1 expression in the germ line and cells that are closely
associated with the germ line has been previously reported
(5–7). It has been suggested that full-length L1 mRNA is
expressed little, if at all, in somatic tissues (8,9), although
it has generally been detected in somatic cells that under-
went malignant transformation (10). Recent reports have
shown, in addition to the germ line, some L1 protein
expression in vascular endothelial cells of human male
gonads, L1 RNA expression in lymphoblastoid cell lines,
and L1 mobilization in the brains of L1-transgenic mice
(7,11,12). Unmethylated L1 loci and L1 mobilization has
been reported in normal human brain (13). Because the
vast majority of the L1 RNA is spliced and/or prema-
turely polyadenylated (14,15), detection of L1 proteins in
a cell is not a reliable indicator of the retrotransposition
potential. Endogenous L1 elements (16), L1 elements
transiently expressed in primary cells (17,18), and in
somatic cells of transgenic mice (11,19–21), are capable
of retrotransposition indicating that there are no intrinsic
molecular limitations for L1 protein activity speciﬁc to
somatic cells.
There are a broad range of factors that lead to DNA
damage, both in the germ line and somatic cells. There has
been a signiﬁcant focus on exogenous (i.e. radiation and
chemicals), as well as endogenous [replication errors and
reactive oxygen species (ROS)], sources of somatic DNA
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integration events and tissue culture experiments, expres-
sion of the functional L1 elements in human cells results in
integration events of L1 as well as its parasites, short
interspersed elements (SINEs) and presumably SVA
elements. While retrotransposition of L1 elements
requires production of the full-length L1 mRNA that
contains both functional ORF1 and ORF2 proteins (4),
SINE retrotransposons (such as Alu elements) rely only
on the production of the functional L1 ORF2 protein in
tissue culture-based assays (22). Alu retrotransposons
have been much more successful than L1 in occupying
the human genome (accumulating to over 1000000
copies) and causing over twice the number of diseases
originated by L1 elements (23,24). This diﬀerence in the
total genomic copy number of L1 and Alu elements may
come from the variation in the retrotransposition eﬃ-
ciency, post-insertional selection, or both.
In addition to insertional mutagenesis, expression of the
functional wild-type (wt) full-length L1, or L1 ORF2
protein alone, in human cancer cells induces DNA
double-strand breaks (DSBs) (25–27) in great excess
relative to the integration events detected under the
same conditions (27). DNA DSBs are known to be
highly toxic and mutagenic even when repaired by the
wt DNA repair machinery in mammals [reviewed in ref.
(28)]. The cellular response to DNA damage usually man-
ifests itself in cell cycle arrest, cell death (apoptosis or
necrosis), or senescence. L1 expression in human cancer
cells has been reported to induce cell cycle arrest (27) and
apoptosis (25,29).
Because L1 expression can contribute to DNA damage
not only through insertional mutagenesis but also via gen-
eration of DSBs, a better understanding of the expression
patterns of endogenous L1 elements, particularly because
of the complex processing of their mRNA (14,15,30),
would provide a more complete picture of the potential
sites of L1-related damage. Our data demonstrate ongoing
L1 expression in a broad spectrum of normal human
tissues including adult stem cells. Both the expression
levels and the L1 RNA processing vary dramatically
among the tissues tested in this study. We provide exper-
imental support that L1-related DNA damage in human
somatic cells is not limited to the production of the
full-length L1 mRNA because of the expression of the
L1 splice transcript that likely contributes to the transla-
tion of the L1 ORF2 protein. The SpORF2 transcript is
detected in numerous human tissues and the expression
of SpORF2 mRNA exhibits tissues-speciﬁc variation.
We also demonstrate that transient expression of the wt
L1 or the splice SpORF2 product in normal human
ﬁbroblasts and adult stem cells leads to a senescence-like
phenotype. Because L1 activity has been well established
to contribute to germ line mutagenesis [reviewed in ref.
(23)], our ﬁnding of somatic L1 expression in a number
of human tissues suggests that L1 elements need to be
considered as an endogenous mutagen not only in germ
line but also in somatic tissues for humans. Our ﬁndings
suggest that even low levels of somatic DNA damage due
to L1 activity have the potential to contribute to genetic
instability, aging, and age-related diseases, such as cancer.
MATERIALS AND METHODS
Cell culture
NIH 3T3 (ATCC CRL-1658), MCF7 (ATCC HTB-22),
HeLa (ATCC CCL2) cells were maintained as described
(14). Human ﬁbroblasts BJ (HCA2) immortalized with
human TERT (31) (a generous gift from Dr J. Campisi)
were passaged as described (31) and cultured in 5% CO2
and 20 or 5% O2 for DNA damaging assay. Human
mesenchymal stem cells (MSCs) were cultured and
maintained as described (32). Frozen vials of exten-
sively characterized human MSCs were used at passage
2–4. MSCs were obtained from the Tulane Center
for Preparation and Distribution of Adult Stem Cells
(http://www.som.tulane.edu/gene_therapy/distribute
.shtml). The cells were recovered from the frozen vials as
passage 2 cells after they reached  80% conﬂuence in 8–9
days and replated at 100cells/cm
2 with a change in
medium every 2–3 days for further analysis.
Alu retrotransposition assay
HeLa cells (500000) per T75 (Corning) were transfected
with 2mg of tagged Alu expression vector (22) and 1mgo f
human ORF2 LIS expression vector (see plasmid
construction in Materials and methods in Supplementary
Data) with 6ml of Plus reagent and 6ml of Lipofectamine
(Invitrogen). Cells were selected with culture media con-
taining geneticin (G418) at 400mg/ml (GIBCO). After
12 days under selection cell colonies were ﬁxed and
stained. To test the activity of endogenously expressed
L1 elements, HeLa cells were transfected with the Alu
reporter gene and empty pCEP4 vector as described
above. Two independent CsCl preparations of AluNeo
and pCEP expression vectors were used for the experi-
ments testing endogenous L1 activity in HeLa cells.
Where standard deviations are stated at least an n of 3
was used to determine the indicated value.
Northern blots
RNA extractions and northern blot analysis was per-
formed as previously described (14,15). Two conﬂuent
T75 ﬂasks were used for cancer cell lines for the analysis
of endogenous L1 expression. PolyA-selected RNA
(Ambion) from various human tissues [human testicle
catalog #7973, prostate #7989, liver #7961, lung #7969,
thymus #7965, ovary (one of the samples was pooled
from three diﬀerent individuals) #7975, brain #7963,
placenta #7951, spleen #7971, pancreas #7955, kidney
#7977, adrenal #7995, cervix #7993 (pooled from ﬁve dif-
ferent individuals), heart #7967, skeletal muscle #7983,
colon #7987, stomach #7997, esophagus #6843] was used
for the analysis of endogenous L1 expression in human
tissues. All tissues were listed as normal. More than one
sample was tested for esophagus, ovaries, testis, prostate
and brain. Where standard deviations are stated for
cancer cell lines at least an n of 3 was used to determine
the indicated value. L1 RNA proﬁles shown in
Supplementary Figure S1A are from diﬀerent individuals
than the RNA used for northern blots shown in Figure 1,
one of the lanes for testis RNA in Supplementary Figure
3910 Nucleic Acids Research, 2010,Vol.38, No. 12S1A contains RNA from the same individual shown in
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RT–PCR
A reverse transcription kit (Promega) was used for reverse
transcriptase (RT)–PCR ampliﬁcation of RNA samples
from diﬀerent tissues according to the manufacture’s
protocol. PolyA-selected RNA, 2ml( 1 mg), from testis,
ovary, placenta and adrenal gland (Ambion) was used
for each reverse transcriptase reaction performed with
ORF2( ) primer (all primer sequences are listed in
Supplementary Figure S5). RNA from the same individ-
uals was used for RT–PCR and northern blot analysis.
Ten micro liters of the diluted RT reaction was used in
the total volume of 100ml with the forward HindIII (+)
primer complementary to the ﬁrst 22bp of the L1.3
50-UTR and nORF2( ) primer. The resulting PCR
reaction, 2ml, was used for the second round PCR per-
formed with nested forward and nORF2( ) primers. PCR
products were analyzed by gel electrophoresis. Bands were
excised, gel puriﬁed by QIAquick Gel extraction kit
(QIAGEN), cloned into TOPO-2.1 vector (Invitrogen)
and sequenced (TGEN, AZ). Identiﬁcation of the
matching genomic L1 loci was done by BLAT
(http://genome.ucsc.edu/cgi-bin/hgBlat).
Plasmid construction
See ‘Materials and Methods’ section in Supplementary
Data for details.
d4T treatment
In order to determine the eﬀective dose of the d4T treat-
ment HeLa cells transiently transfected with a neomycin
tagged L1 (L1), with a neomycin tagged Alu (Alu) and a
non-tagged L1 expression vector (Alu+L1), or an
unrelated plasmid containing the neomycin resistance
gene (Neo control) were treated with diﬀerent doses of
20,30-didehydro-30-deoxy-thymidine, d4T, (0–50mM) for 7
days as previously reported (33). Following the treatment,
cells were grown in the presence of G418 for 14 days, after
which the NeoR colonies were stained and counted
(Figure 5A). A dose of 50mM of d4T was used for
7 days in the follow up experiment to determine the depen-
dence of the Alu NeoR generated colonies on the func-
tional endogenous L1 reverse transcriptase activity.
Neutral COMET assay
HeLa cells, 10
6, were plated per T25 18–20h prior
transfection with 3mg of respective constructs by
Lipofectamin reagent (Invitrogen). Cells were trypsinized
24h post-transfection and resuspended in Ca- and Mg-
free PBS (10
5 cells/ml). One half of the untreated cells
was subjected to 5Gy of ionizing radiation. Neutral
Comet Assay was performed according to the direc-
tions supplied with Trevigen Reagent Kit for Higher
throughput single cell gel electrophoresis assay
(Trevigen, catalog #4252-040-K). For more details see
‘Materials and Methods’ section in Supplementary Data.
DNA damage assay
Normal human ﬁbroblasts at 2500 per well (96-well plate)
immortalized with Htert (31) were plated and transiently
transfected the next day with 0.03mg/well of the empty
(pCEP4), L1wt or SpORF2 vectors by lipofectamine
2000 following the manufacturer’s protocol. Cells were
grown in 5% CO2 and 5% O2. The transfection cocktail
was left on the cells for 20h after which the cells were ﬁxed
and probed with 53BP1 speciﬁc rabbit polyclonal
antibody (Novus Biologicals) and Alexa 488 second-
ary anti-rabbit antibody (Invitrogen) according to the
BD Biosciences protocol (http://www.bdbiosciences.com
/cgi-bin/literature/archive?type=8&brand=5). Hoechst
(Invitrogen) staining was done during the incubation
with secondary Ab. Treatment with 1.85mM of H2O2
for 10min was used as positive control. Pictures of
random ﬁelds were taken by a BDPathway 855 at
40 magniﬁcation.
Senescence assay
Fifty thousand BJ (HCA2) or human MSCs per well in the
six-well plates were transfected with 0.1mg of the respec-
tive DNA by Lipofectamine 2000 (Invitrogen) in 1ml of
media supplemented with serum for 5h. Zeocin treatment
included exposure to 400mg/ml in serum-supplemented
media for 5h. Forty-eight hours post-transfection
cells were ﬁxed and stained for detection of senescence-
associated b-galactosidase (SA-b Gal) activity with
Senescence Detection Kit (BioVision) according to the
manufacturer’s protocol. The time of incubation at 37 C
was adjusted to 6–10h instead of overnight. Cells
were analyzed under LEICA DMIRB microscope at
200 total magniﬁcation. Six random pictures were
taken for each well and blue cells were scored in
Microsoft Photodraw V2 program and expressed as a per-
centage of the total cells present in each ﬁeld. Data were
normalized to the percentage of the blue cells detected
in the non-transfected control. Each experiment was
repeated independently three times for each construct
and cell type. MSCs from two independent donors
were used.
RESULTS
L1 mRNAs are expressed in somatic human tissues
Previous reports that mouse L1 mRNA and protein
expression is detected primarily in the germ line (5,6)
lead to extrapolation that the human L1s follow the
same pattern. We performed northern blot analysis of
RNA extracts from normal human tissues with a
strand-speciﬁc RNA probe complementary to the ﬁrst
hundred base pairs of the L1 sequence (Figure 1A,
50-UTR 100bp probe) that detects all known L1
mRNAs (14). We found highly variable expression of
endogenous L1 among somatic human tissues, with the
amount of the full-length (FL) L1 levels in some tissues
comparable to those detected in cancer cells. Northern
blot analysis demonstrated that relative expression
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Figure 1. Endogenous L1 expression in normal human tissues. (A) A schematic representation of the L1 structure and some transcription products
detected in normal tissues and cancer cells. Full-length L1 (FL1) element contains a 50-UTR, two open reading frames 1 and 2 (ORF1 and 2),
30-UTR and a polyadenylation signal (pA). L1 transcription results in the production of the full-length L1 (FL1) mRNA, prematurely
continued
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agus, prostate, stomach and heart muscle is at about 80, 50,
150 and 200%, respectively, of the levels detected in HeLa
cells (Figure 1B–D). The levels of the FL L1 in adrenal
gland, spleen, kidney, cervix and several other tissues are
below the sensitivity of the assay, and thus cannot be accu-
rately assessed. The sum of all L1-related transcripts in
testis is as much as an order of magnitude higher than in
other tissues. This observation is consistent with the
previous report of the 10-fold transcriptional activation of
the L1 promoter by testis-determining factor gene SRY
(34). Despite having the highest total L1 mRNA levels,
testis FL L1 RNA production appears to be severely
restricted by RNA processing. This result was conﬁrmed
by northern blot analysis of testis RNA extracts obtained
from diﬀerent individuals (Supplementary Figure S1A, out
of the two lanes for testis RNA in this ﬁgure one is from the
same individual as in Figure 1). In comparison, the propor-
tion of the FL L1 mRNA relative to the total L1 RNA
productioninothertissuesvariedfromalmostundetectable
levels of FL L1 RNA, as in the testis, to 16.6% (SD=6.7)
in the ovary (Supplementary Table S1).
All human somatic tissues evaluated in this study
express L1-related mRNAs with varying degrees of
processing. Some of the smaller L1-derived RNAs are
ubiquitously expressed and comigrate with the previously
identiﬁed processed L1 mRNAs produced by transiently
transfected human wild-type and mutant L1.3 elements
(L1.3 and L1.3M) (Figure 1) (14,15,30). Other transcripts
exhibited tissue-speciﬁc expression patterns. Although it is
possible that some of the bands that do not comigrate
with the previously characterized L1 RNAs could repre-
sent hybrid transcripts between L1 and cellular genes, this
seems unlikely given the low levels detected for such
hybrid transcripts (14). To distinguish between spliced
and polyadenylated L1 mRNAs, the same RNA blots
were evaluated with the 50-UTR 600bp probe comple-
mentary to the L1 50-UTR region often removed by
splicing (14) (Figure 1). Our results demonstrate that L1
elements undergo splicing and polyadenylation in most of
the tested human tissues (Figure 1). However, in some
tissues, such as testis, splicing is more dominant than
in others, such as stomach, that produces almost
exclusively prematurely polyadenylated products.
Endogenous full-length L1 mRNA expression inversely
correlates with the production of the spliced and
polyadenylated L1 species
We have previously reported that splicing and premature
polyadenylation attenuate full-length L1 mRNA
production (14,15). The observation of diﬀerential L1 pro-
cessing in normal human tissues suggests that the produc-
tion of the full-length L1 mRNA in various tissues may
depend not only on the L1 promoter strength but also on
the amount of the RNA processing supported by a speciﬁc
cell type. A primary example is testis where overall high
expression of the L1-related mRNAs indicates eﬃcient L1
transcription (Figure 1 and Supplementary Figure S1A),
whereas the full-length L1 transcripts remain below the
detection sensitivity of the assay.
To determine whether premature polyadenylation and
splicing play a similar role in malignant cells, endogenous
L1 RNA proﬁles were analyzed in breast and cervical
cancer cell lines. Northern blot analysis demonstrated
variation in the quantity and pattern of the truncated
endogenous L1 products between the transformed cell
lines in a manner similar to that observed in somatic
tissues. The size and processing of the truncated
L1 RNAs in HeLa cells correlates well with the tran-
scripts detected for transiently transfected L1
elements [Supplementary Figure S1B and (14)]. The
faster migrating bands in HeLa cells represent spliced L1
RNA as conﬁrmed by northern blot analysis with the
strand-speciﬁc 50-UTR 600bp probe. Similar to
human somatic tissues, some of the processed L1
products were detected in all tested cell lines (Figure 2,
pA).
Quantitative evaluation of the L1-related products
detected by northern blot analysis in human cancer cells
shows that the MCF7 breast cancer cell line supports the
highest full-length L1 expression. On the other end of
the spectrum are HeLa cells that produce  15% of the
full-length L1 relative to the L1 expression levels in MCF7
cells. Despite the over 5-fold diﬀerence in the relative
full-length L1 mRNA production between MCF7 and
HeLa cells, the expression of the total L1-related
products are roughly the same in the two cell lines
(Figure 2C, total L1, gray bars), suggesting relatively
equal steady-state presence of L1 mRNAs in these cell
lines. In part, the observed discrepancy is due to the fact
that  50% of the mRNA products in MCF7 cells are
full-length, while only 10–15% of the L1-related species
are full-length in HeLa cells (Figure 2C, FL%, black
bars), indicating that there is an inverse correlation
between the amount of the truncated L1 species and the
FL RNA. These results are comparable to those in human
somatic tissues where placenta and ovary generated the
lowest amount of the truncated L1 mRNAs with
the highest FL L1 expression relative to the total L1
transcripts [16.5 and 16.6% (SD 6.7), respectively]
(Supplementary Table S1).
Figure 1. Continued
polyadenylated mRNAs (pA), and spliced and polyadenylated mRNAs (Sp), one of which has the potential to express L1 ORF2 protein alone
(SpORF2) as conﬁrmed by its capability to mobilize Alu in a tissue culture assay (see Figure 4B). Dashed lines correspond to the L1 sequences that
are removed by splicing. Horizontal arrows indicate relative positions of the strand-speciﬁc 50-UTR 100bp and 50-UTR 600bp probes used for
northern blot analysis in this study. (B–E) Northern blot analysis of the endogenous L1 expression in various adult human tissues. Es, esophagus; St,
stomach; Col, colon; SM, skeletal muscle; HM, heart muscle; Cer, cervix; Adr, adrenal gland; Kid, kidney; Spl, spleen; Pan, pancreas; Br, brain; Ts,
testis; Ov, ovaries; Pl, placenta; LN, lung; PR, prostate; TH, thymus; LV, liver. The very left lane shows L1.3wt (L1.3) and mutant (L1.3M) that
contains a mutation in the strongest polyA site (15) expression proﬁles in NIH 3T3 cells transiently transfected with these human L1 expression
vectors. L1 transcription results in the production of the full-length L1 (FL1) mRNA, prematurely polyadenylated mRNAs (pA), and spliced and
polyadenylated mRNAs (Sp) one of which has the potential to express L1 ORF2 protein (SpORF2). Actin denotes b-actin mRNA detected with a
strand-speciﬁc probe.
Nucleic Acids Research, 2010,Vol.38, No. 12 3913These data demonstrate that even though L1 promoter
strength is an imperative determinant of the L1 expres-
sion, post-transcriptional L1 mRNA processing is a
powerful mechanism that can ultimately control the
full-length L1 expression not only in normal but also in
malignant human cells.
Human adult stem cells support endogenous L1 expression
Because diﬀerentiated somatic cells originate from adult
stem cells, we wished to determine whether adult stem cells
support endogenous L1 expression. Northern blot analysis
of the L1 expression and RNA proﬁles was carried out for
human bone marrow-derived MSCs (32). These cells pro-
duce endogenous L1 transcripts with very extensive RNA
processing (Figure 2B). Northern blot analysis with the
50-UTR 600bp strand-speciﬁc probe demonstrated that
MSCs support eﬃcient production of the processed
mRNAs consistent with the characterized in somatic and
cancer cells (Figure 2B, 50-UTR600bp probe). They also
produce processed L1 mRNAs that are speciﬁc to MSCs
(Figure 2, bands marked with asterisks). Quantitative
analysis of the northern blot results demonstrated that
expression of the L1-related species in MSCs is at 20%
of the total steady-state levels of the L1 expression
detected in MCF7 cells. However, due to the extensive
RNA processing, the amount of the full-length L1 tran-
script is below the sensitivity of the assay in adult stem
cells and, therefore, cannot be quantitatively evaluated.
These data indicate that eﬃcient L1 expression is sup-
ported in a broad spectrum of human somatic tissues
including adult stem cells, with highly variable post-
transcriptional processing. This processing appears to rep-
resent one of the major variations in full-length L1 mRNA
expression and presumably activity.
Figure 2. Endogenous L1 expression in human adult stem cells and cancer cell lines. (A) Schematic of the full-length L1 element (FL1) and the
ORF2 splice product (SpORF2). Arrows indicate the positions of the RNA strand-speciﬁc probes. (B) The left panel represents northern blot
analysis of the RNA proﬁles of endogenously expressed L1 elements in human cervical (HeLa) and breast (MCF7) cell lines and human
mesenchymal stem cells (MSCs) using the 50-UTR 100bp RNA strand-speciﬁc probe. The right panel is the same northern blots probed with the
50-UTR 600bp strand-speciﬁc RNA probe that detects polyadenylated, but not spliced, L1 mRNA. See Supplementary Figure S1B for the northern
blot with the ORF2 probe. FL1, pA, Sp, SpORF2 and actin are marked as described in Figure 1. Asterisks mark bands speciﬁc to human MSCs.
(C) Relative L1 expression and processing in MCF7 and HeLa cells. Black bars indicate the amount of the full-length L1 mRNA as a percentage of
the total L1-related products detected in each cell line with the 50-UTR 100bp probe (scale shown at the left y-axis). Gray bars represent expression
of all L1-related transcripts detected in each cell type relative to actin mRNA expression (scale shown at the right y-axis). Note that even though
both cell lines express similar steady-state levels of the total L1 mRNAs, the full-length L1 mRNA composes only 10% of the total L1 products in
HeLa cells compared to over 50% in MCF7 cells.
3914 Nucleic Acids Research, 2010,Vol.38, No. 12Diﬀerent somatic tissues express endogenous L1 splice
variants with potential biological relevance
We have previously reported functional splice sites within
L1 sequence usage of which can remove the entire ORF1
sequence but leave ORF2 intact (14) generating the
SpORF2 product. The resulting mRNA would have the
potential to make functional L1 ORF2 protein indepen-
dent of the FL L1 mRNA (Figures 1 and 2). One of the
products detected in some normal human tissues, adult
stem cells and human cancer cell lines was consistent
with the SpORF2 RNA species based on its size and
detection with the 50-UTR 100bp and ORF2 probes but
not with the 50-UTR 600bp probe (Supplementary
Figure S1B). The amount of this mRNA relative to the
amount of the FL L1 mRNA or the total L1-related
products varies signiﬁcantly among human tissues
(Supplementary Table S1).
Usage of the splice sites to generate SpORF2 mRNA in
normal tissues was conﬁrmed by sequencing of the cDNA
obtained by RT–PCR ampliﬁcation using primers comple-
mentary to the beginning of the L1.3 50-UTR and L1
ORF2 (Figure 3A). RT–PCR produced two L1-speciﬁc
bands in testis, ovary, placenta and adrenal gland
(Figure 3B), one of which was of the expected size for
the previously reported SpORF2 identiﬁed in HeLa cells
(14). Sequence analysis of independent clones conﬁrmed
that the faster migrating band is a product of L1 splicing
from position 97 to 1837 (coordinates are given relative to
the L1.3 accession L19088) as documented previously
(14). The slower migrating band is a product of splicing
from position 290 to 1920. This second L1 mRNA is also
predicted to support translation of ORF2. The same
bands were detected by RT–PCR in human MSCs and
MCF7 cells (Supplementary Figure S2A). Recovered
splice junction sequences matched active (L1Hs) and
inactive L1 subfamilies consistent with the previous
reports of multiple L1 loci expressed in human cancer
and embryonic stem cells (10,35) (Supplementary Figure
S2B and C). In addition to the youngest L1 loci that can
generate full-length L1 ORF2 this limited cDNA analysis
identiﬁed L1 loci that can express 30-truncated ORF2
proteins. Even though retrotranspositionally incompetent,
these proteins retain the endonuclease (EN) domain of the
L1 ORF2. L1 EN expressed as a truncated fragment of the
L1 ORF2 has been shown to possess DNA damaging
activity in vitro (36). These data indicate that splice
variants that have a potential to express L1 ORF2 inde-
pendent of ORF1 are likely to be commonly expressed in
human somatic tissues including those that do not dem-
onstrate SpORF2 expression by northern blot analysis
(i.e. adrenal gland).
Northern blot analysis with the strand-speciﬁc 100bp
50-UTR RNA probe was used to determine the relative
expression of the SpORF2 product among human
somatic tissues as a function of the actin mRNA expres-
sion (Figure 1). This quantitative evaluation determined
that esophagus, prostate and lung support expression of
the L1 SpORF2 mRNA at the levels very similar to those
detected in HeLa cells (90, 70 and 80% respectively). In
contrast, heart muscle and testis produce 5- 6-fold more
SpORF2 mRNA than HeLa cells, while thymus, placenta
and stomach generate intermediate levels of this product.
As much of the SpORF2 product as the FL L1 mRNA is
detected in HeLa cells and heart muscle, while testis, lung
and adrenal gland support signiﬁcantly higher steady-state
levels of the SpORF2 mRNA than the FL L1 transcript
(Figure 1 and Supplementary Figure S1). The SpORF2
product in the human MCF7 cancer cell line is produced
at 26±3.4% of the endogenous FL L1 mRNA detected
in these cells. Relative SpORF2 expression in HeLa and
MCF7 cells is very similar despite the signiﬁcant diﬀerence
in the full-length L1 mRNA expression between the two
cell lines. These data suggest potential tissue-speciﬁc vari-
ation in the cellular exposure to L1-induced damage,
depending on the amount of the FL L1 and SpORF2
products in both normal and cancer cells.
Expression of SpORF2 splice product can support Alu
mobilization
Because the SpORF2 RNA 50-UTR contains a potential
alternative AUG, expression of this RNA may not lead
to the eﬃcient L1 ORF2 translation. To conﬁrm that
identiﬁed spliced variants can eﬀectively translate L1
ORF2 protein when they precede functional L1 ORF2
sequence, recovered cDNAs of spliced 50-UTRs were
subcloned upstream of an active L1 ORF2 inserted into
a mammalian expression vector driven by the SV40
promoter (Supplementary Figure S3A). Sp97/1837
(recovered from NIH 3T3 cells transiently transfected
with L1.3), Sp97/1837E and Sp290/1920E (recovered
from endogenously expressed L1s in somatic human
tissues) constructs reconstitute the spliced 50-UTR of the
SpORF2 mRNA products detected in vivo. We used an
Alu retrotransposition assay, which requires only the L1
ORF2 protein in cultured human cells (22) to generate Alu
Figure 3. Various adult human tissues support production of the
spliced L1 transcript that has a potential to produce ORF2 protein.
(A) Schematic of the full-length L1 element (FL1) and the spliced
ORF2 transcript (SpORF2). Arrows indicate the positions of the
RT–PCR primers. (B) RT–PCR analysis of the L1 splice products in
human Ts, testis; Ov, ovary; Pl, placenta; Ad, adrenal gland. RT(+)
and RT( ) panels indicate reactions with and without RT, respectively.
100M, 100bp marker. The two diﬀerentially migrating bands represent
L1 splice products utilizing various L1 splice donor and acceptor sites
(indicated on the left).
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colonies (Figure 4A), as an indicator of the functional
L1 ORF2 translation from these constructs (22). Alu
retrotransposition assays in HeLa cells demonstrated
that splice variants support Alu mobilization in HeLa
cells as well as the expression vector containing no
L1 sequences upstream of the L1 ORF2 (pGL3LIS)
(Figure 4B and Supplementary Figure S3B). Although
FL L1 mRNAs are almost certainly crucial for L1
retrotransposition, our data demonstrating the ability of
the spliced product, SpORF2, to make functional ORF2
protein indicate that damage from Alu insertion may
occur independently of the FL L1 RNA expression and
L1 retrotransposition. This discovery contrasts with
previous assumptions that the only source of functional
ORF2 is the FL L1 mRNA (37,38). A potential of the
functional L1 ORF2 production by the retrotranspo-
sitionally incompetent full-length L1 mRNA independent
of the ORF1 translation has been previously suggested
(22). The presence of the L1 splice product, SpORF2, in
a variety of somatic tissues and cancer cells provides and
alternative mechanism for the L1 ORF2 production by
both retrotranspositionally competent and incompetent
transcriptionally active L1 loci containing wt ORF2
sequence.
Endogenously expressed L1s have a potential to produce
functional ORF2 protein
Because many FL genomic L1 elements have mutations
that inactivate their reading frames (2), having L1-related
RNAs does not guarantee that they are making functional
products. We hypothesized that HeLa cells can support
exogenously expressed Alu retroposition if the functional
L1 ORF2 protein is generated in these cells by either the
full-length L1 mRNA or the SpORF2 product. HeLa cells
transiently transfected with the Alu retrotransposition
cassette described in Figure 4A (22) in combination with
1mg of the vector expressing an exogenous L1 element (39)
or the empty vector resulted on average in 1249±69.3
and 52.6±17.34 NeoR colonies, respectively.
To determine that generation of these NeoR colonies
depends on the functional L1 RT activity, we used a
HIV RT inhibitor 20,30-didehydro-30-deoxy-thymidine,
d4T or stavudine, which has been shown to inhibit L1
RT function in a competitive manner (33,40). These
previous studies demonstrated that these levels of inhibi-
tor do not have any adverse impact on cell growth or
colony formation. Figure 5A demonstrates that treatment
of HeLa cells with increasing doses of d4T resulted in the
dramatic reduction of both L1, as well as Alu retrotran-
sposition driven by exogenous L1 (Alu+L1), while the
same treatment of the HeLa cells transiently transfected
with a neomycin (Neo) expression vector had very little
eﬀect on the formation of the NeoR colonies through
random integration. L1 and Alu element retrotran-
sposition requires target-primed reverse transcription
(TPRT) (41), the control transfection with unrelated
Neo expression vector relies on the plasmid integration
into the host DNA and does not depend on the presence
of the functional RT. Equal numbers of colonies formed
Figure 4. SpORF2 splice product can produce functional L1 ORF2
protein. (A) Experimental approach for L1 ORF2-dependent Alu
retroposition. An Alu element (gray box) tagged with a backwards
neomycin resistance (NeoR) gene (22) (white arrow indicating the ori-
entation of NeoR transcription) expression of which is driven by a
promoter (black box marked with P) in the orientation opposite of
the Alu transcription. NeoR gene ORF is interrupted by a self-splicing
intron that is removed upon Alu transcription and a functional NeoR
gene can be expressed upon tagged Alu retroposition. The tagged Alu
expression cassette is transfected into HeLa cells with the wt L1,
SpORF2 expression vectors or tagged Alu vector alone, which detects
‘background activity’ generated by the endogenously expressed L1
ORF2. (B) SpORF2 L1 RNA products can produce functional
ORF2 protein to drive Alu retroposition in tissue culture. A
mean±SD of NeoR colonies for each construct is shown (see
Supplementary Figure S3A for construct design and Supplemenatry
Figure S3B for additional controls). (C) Transient expression of
SpORF2 splice product in HeLa cells leads to DNA damage. HeLa
cells were transiently transfected with the empty or SpORF2 expression
vector, or subjected to 5Gy of IR. Neutral COMET assay was per-
formed and a mean±SD of the tail extent moment from three inde-
pendent experiments is shown. Asterisks indicate statistically signiﬁcant
diﬀerence between the treatments and the control empty vector (t-test,
P<0.05).
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expression vector with, or without, d4T treatment
indicating that the exposure to this chemical has no detect-
able toxic eﬀect on the cells. Exposure to d4T of HeLa
cells transiently transfected with the tagged Alu expression
vector alone resulted in the disappearance of the NeoR
colonies. The apparent inability of the exogenous tagged
Alu to form NeoR colonies in the presence of the inhibitor
of the L1 reverse transcriptase activity indicates that these
Alu-generated colonies depend on the endogenous L1 RT
activity, supporting endogenous expression of functional
L1 ORF2 protein in HeLa cells.
To further characterize NeoR colonies formed by Alu
without any exogenous source of L1, DNA from eight
colonies generated in HeLa cells transfected with Alu
and the empty vector was recovered and analyzed by
PCR to evaluate the absence/presence of the self-splicing
intron (Figure 5B and C, and Supplementary Figure S4).
All evaluated colonies were conﬁrmed as bonaﬁde
retrotransposition events. These data support endogenous
expression of functional L1 ORF2 in HeLa cells and are
consistent with the previous reports of the endogenous
expression of the functional L1 elements in human
(10,35) and rat (42) cells as well as mobilization of
exogenously expressed Alu by the functional endogenous
L1 proteins in mouse and human cells (22,43,44).
SpORF2 expression causes DNA damage
Previous reports demonstrated that expression of the wt
L1 element, or L1 ORF2 alone, in cancer cells leads to
DNA damage in the form of DSBs (25–27) that can
trigger cell cycle arrest (27) or apoptosis (25,29). Because
multiple somatic tissues and tumor cell lines support
SpORF2 formation without, or in parallel with, the pro-
duction of the full-length L1 mRNA, we wished to deter-
mine whether SpORF2 could produce DNA damage in
these cells independent of the full-length L1. HeLa cells
were transiently transfected with the SpORF2 construct
and DNA damage was assessed by a neutral COMET
assay that detects DNA DSBs (45). Gamma irradiation
was used as a positive control. Figure 4C demonstrates
that transient expression of the SpORF2 splice product
resulted in an increase in the average tail moment that
corresponds to DNA damage compared to the cells
transfected with the empty vector. This result is consistent
with the previous observation of g-H2AX foci formation
after L1 ORF2 expression in HeLa cells (27).
DNA damage was also assessed in normal human
ﬁbroblasts transiently transfected with empty vector or
vectors expressing wt L1 or SpORF2 splice product by
detecting p53-binding protein 1 (53BP1) foci in response
to DNA DSBs with antibody speciﬁc to this protein.
53BP1 is one of the characterized responders recruited
to the sites of DNA DSBs (46). Detection of 53BP1 foci
Figure 5. Endogenously expressed L1 ORF2 supports exogenous Alu
retroposition in HeLa cells. (A) Eﬀect of d4T on the neomycin resistant
colony formation. HeLa cells transiently transfected with a neomycin
tagged Alu supplemented with non-tagged L1 (Alu+L1), a tagged L1
(L1) or an unrelated plasmid containing neomycin resistance gene (Neo
control) were treated with diﬀerent doses of 20,30-didehydro-30-
deoxy-thymidine, d4T, (0–50mM) for 7 days. Following the treatment,
cells were grown in the presence of G418 for 14 days, after which the
NeoR colonies were stained and counted. The results from the
untreated (0mM) cells were arbitrarily assigned as 100% (dashed
line). The relative percentage means±SD are shown. The total
number of colonies observed for the diﬀerent dose treatments are
indicated above each column. No signiﬁcant eﬀect on the colony for-
mation was detected for the d4T treated control (neo control) when
compared to the untreated sample (P>0.5, paired t-test). Both tested
d4T doses signiﬁcantly aﬀected the ability of the tagged L1 and Alu
vectors to generate Neo resistant colonies through the retrotrans-
position process (P 0.03, paired t-test astersik). (B) Schematic repre-
sentation of the Alu expression vector (gray rectangle) tagged with
neomycin gene (white arrow) interrupted by a self-spliced intron
(SSI). P designates promoter that drives functional Neo gene expression
only after successful retroposition. Black arrows indicate relative posi-
tions of the primers used in PCR ampliﬁcation speciﬁcally designed to
distinguish between a spliced retrotransposed insert and the original
unspliced vector sequence [(AluNeo(+) and AluNeoEx1( )]. Primer
sequences are shown in Supplementary Figure S5. To increase
speciﬁcity, the upstream primer is speciﬁc to the Alu construct, so
that this pair of primers will not amplify NeoR gene present in other
expression vectors to eliminate detection of any potential contamina-
tion from the neo/kan-expressing plasmids (Supplementary Figure S4).
(C) PCR analysis of DNA recovered from the neomycin resistance
(NeoR) colonies generated in HeLa cells without supplementation
with the exogenous L1 expression vector. The size of the generated
PCR product corresponds to the spliced NeoR gene in the Alu expres-
sion vector. AV is Alu expression plasmid (positive control for
unspliced product). NV is non-Alu neomycin expression vector
(negative control for speciﬁc Alu ampliﬁcation). NC is negative
control (PCR reaction without DNA template). M is DNA marker.
Nucleic Acids Research, 2010,Vol.38, No. 12 3917with 53BP1 speciﬁc antibody demonstrates a signiﬁcant
increase in the number of cells with DNA DSBs as well
as in the average number of breaks per cell in normal
human ﬁbroblasts transiently transfected with L1 and
SpORF2 expression vectors relative to the empty vector
control (Figure 6A–C). These data are consistent with the
previous reports of L1-induced DNA damage in cancer
cells and support the idea that SpORF2 expression in
normal cells may contribute to genomic instability inde-
pendent or in addition to the full-length L1-associated
insult to DNA integrity.
Expression of exogenous full-length L1 and SpORF2 in
normal human ﬁbroblasts, and adult stem cells results
in the senescence-like phenotype
L1 elements have been reported to compromise the
integrity of the cellular DNA via the introduction of
DSBs (25–27). DSBs are normally highly toxic and
mutagenic to mammalian cells and have previously
been associated with apoptosis triggered by L1 expres-
sion (25,27). Another common cellular response to
DNA damage often occurring in normal cells is senes-
cence. Senescent cells express senescence-associated
b-galactosidase detection of which is routinely used as a
marker of cellular senescence (47). Exposure to a number
of DNA damaging agents leads to cellular senescence (48).
To determine whether creation of DNA damage in mam-
malian cells by L1 elements can also result in cellular
senescence, normal human ﬁbroblasts immortalized with
human telomerase (31), and MSCs were transiently
transfected with either empty vector, a vector carrying
wt L1.3 element or an SpORF2 expression vector. For
the positive control, cells were treated with a DNA
damaging agent zeocin. Both cell types exhibited a
senescence-like phenotype in response to the FL L1
expression and L1ORF2 as supported by the expression
of senescence-associated b-galactosidase (Figure 7) (47).
L1 transfected cells also showed some morphological
characteristics of senescent cells much like ﬁbroblasts
treated with zeocin (49) (Figure 7A) and consistent with
the data obtained for cancer cells (29). These data estab-
lish that expression of retrotranspositionally active L1s or
ORF2 protein alone can compromise the integrity of the
normal cell function and lead to a senescence-like
phenotype reminiscent of the stress-induced premature
senescence triggered by other DNA damaging agents (50).
DISCUSSION
The ﬁeld of human mobile elements has often focused on
their mutagenic eﬀect within the germ line (5,6) because
transposable element ampliﬁcation to high copy number
in the genome is dependent on germ line insertions.
Detection of endogenous FL or SpORF2 L1 transcripts
in this study in many tested adult tissues broadens the
potential impact of mobile elements on human health
and development. Our ﬁndings of modest levels of the
FL L1 expression in human ovary and testis, and expres-
sion of only processed L1 mRNAs in kidney, lung, liver
and brain are in agreement with the reported expression in
a transgenic mouse model (8). However, sporadic tissues,
such as esophagus, placenta and prostate demonstrate
that some somatic tissues can express L1 elements fairly
well. A recent report of L1 mobilization in a transgenic
Figure 6. L1 and SpORF2 expression in normal human cells results in
DNA damage. (A) Normal human ﬁbroblasts transiently transfected
with the empty vector or vectors expressing L1 or SpORF2 were
analyzed for 53BP1 foci formation 21h post-transfection. 53BP1 is
one of the characterized responders recruited to the sites of DNA
DSBs and it is commonly used as a marker for DNA DSBs.
Treatment with 1.85mM of H2O2 for 10min was used as positive
control. Overlay of Hoechst and antip53BP antibodies is shown.
Arrows indicate cells with distinct staining foci. (B) Quantitation of
the 53BP1 foci positive cells as a percent of the total cells
(mean±SD). Asterisks indicate signiﬁcant diﬀerence determined by
paired t-test with P=0.024, 0.014, 0.001 for L1, spORF2 and H2O2,
respectively. (C) Quantitative assessment of the average number of
53BP1 foci per cell (mean±SD). Asterisks indicate signiﬁcant diﬀer-
ence determined by paired t-test with P=0.003, 0.017 and 0.006 for
L1, spORF2 and H2O2, respectively.
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rates in somatic tissues than in the germ line (21), suggest-
ing the possibility that expression of endogenous L1
elements in diﬀerentiated tissues may result in an
appreciable amount of damage over time. Although FL
L1 mRNAs are certainly the dominant source of L1
retrotransposition, generation of the SpORF2 transcript
that can make functional ORF2 protein indicates that the
FL L1 transcripts with both functional ORFs are not
absolutely required to cause cellular damage. This con-
trasts with previous assumptions that functional ORF2
protein can only be produced from the FL mRNAs
(37,38). It is apparent that detection of the L1 ORF2
protein does not necessarily guarantee the presence of
the full-length L1 mRNA.
Insertion of L1 elements is not the only mechanism by
which they may damage genomes. It is well accepted that
L1 element expression is a necessary driver for insertion of
Alu and presumably SVA elements (22,51), as well as pro-
cessed pseudogenes (52). More importantly, only expres-
sion of the ORF2 of L1 is required to drive Alu
mobilization (22). Thus, tissues that make spliced forms
of L1 RNA but not the FL L1 transcripts may make func-
tional ORF2 and cause mutations by driving Alu
retrotransposition.
There are almost twice as many Alu inserts as
L1 integrants that have been characterized as causing
disease [reviewed in ref. (23)]. In addition, there are
twice as many total Alu elements as L1 copies in the
human genome (2). Even though diﬀerential post-
integration selection against L1 and Alu inserts and a
bias in detection of the disease causing integration
events can certainly account for some of the disparity in
their accumulation rate, it is also possible that the relative
paucity of the full-length L1 mRNA in testis and expres-
sion of the SpORF2 splice product in both testes and
ovaries may promote potentially higher rate of Alu
retrotransposition relative to L1. Thus, the presence of
the SpORF2 products in germ line may contribute to
the higher copy number of Alu elements in the genome
(2) and their higher contribution to disease (53) relative to
L1 inserts.
Methylation and promoter strength were originally
thought to be the only major regulatory mechanisms
restricting L1 activity (54,55). Recently cellular factors,
such as the APOBEC3 gene family and the nuclear
excision repair endonuclease complex ERCC1/XPF (56)
and the potential of RNAi (57), were shown to negatively
modulate L1 retrotransposition (58–60). Even though
transcriptional activity of the L1 promoter is almost cer-
tainly a crucial step in ensuring endogenous L1 expression,
our data demonstrate that it is not the only mechanism
controlling production of the retrotranspositionally active
L1 mRNA. Although polyadenylation and splicing were
previously shown to limit expression of L1 elements, this is
the ﬁrst demonstration that diﬀerential processing of
endogenous L1 mRNA can account for considerable dif-
ferences in the relative abundance of the full-length L1
transcript. Our studies demonstrate that in most tissues
and cell lines, post-transcriptional regulation of L1 RNA
is a major factor in controlling L1 expression (Figures 1
and 2).
In addition to the mobilization of itself and its parasites,
L1 activity also produces DNA DSBs (25–27). Consistent
with the previous reports of DNA damage induced by
Figure 7. Full-length L1 and SpORF2 expression triggers
senescence-like phenotype in normal human ﬁbroblasts and human
adult stem cells. (A) Normal human ﬁbroblasts transfected with the
empty vector, vectors expressing wt L1, or SpORF2, or treated with
a DNA damaging agent zeocin. Blue color represents cells that express
senescence-associated b-galactosidase. (B) Quantitation of the
L1-induced senescence in normal human ﬁbroblasts, BJ, immortalized
with human telomerase. Black bars represent relative amount of
senescent cells among human ﬁbroblasts treated as described in (A).
Grey bars represent relative amount of cells observed after each treat-
ment in any given ﬁeld. Asterisks indicate statistically signiﬁcant diﬀer-
ence between the cell numbers of cells transfected with the empty vector
and cells transfected with the wt L1 expression cassette or zeocin treat-
ment (t-test, P-value 0.014 and 0.00025, respectively). Untransfected
(untr.) is mock-transfected cells. (C) Quantitation of the L1-induced
senescence in human adult stem cells. Black and gray bars represent
relative amount of senescent cells and total cells as described in (B).
Asterisks indicate statistically signiﬁcant diﬀerence between the cell
numbers of cells transfected with the empty vector and cells transfected
with the wt L1 expression cassette, zeocin treatment, or SpORF2
vectors (t-test, P-value 0.01, 0.0002 and 0.013, respectively).
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demonstrate that expression of the SpORF2 splice
product in normal human ﬁbroblasts leads to detectable
DNA damage. This observation suggests that even very
low levels of the L1 ORF2 activity in somatic tissues
generated from either the full-length L1 or the SpORF2
splice product may contribute to the gradual accumula-
tion of DNA damage during the lifespan of an individual.
This damage can be in the form of de novo integration
events of retroelements that can alter gene architecture
and expression (14,61,62), point mutations resulting
from the error-prone repair of ORF2-induced DNA
lesions, or recombination events triggered by the ORF2
nicking activity [reviewed in ref. (63)]. Furthermore, the
ability of L1 elements to produce the SpORF2 splice
product means that even retrotranspositionaly incompe-
tent L1 elements that maintain intact ORF2 can generate
DNA damage (27,36) and mobilize Alu elements (22). As
summarized in Figure 8 cells, such as adult stem cells,
which predominantly produce the SpORF2 transcript
are likely to endure little damage associated with the
full-length L1 mRNA. While prostate, esophagus,
ovaries and a number of other cell types that produce
both the full-length and the SpORF2 mRNAs are
possibly exposed to the full arsenal of the L1-related
genomic instability. Thus, L1 elements may potentially
contribute, in a way similar to ROS, to both the
organismal aging process as well as to a number of
age-related diseases potentially in a tissue-speciﬁc
manner. It is even possible that overproduction of L1
elements in cells still expressing p53 (25) could lead to
cell death that may serve as a defense mechanism
against L1 activity promoting genomic instability that
has a potential to contribute to malignant transformation.
There is also potential for increased L1-related damage
with age because of decreased DNA repair response in
aging mammalian cells (64–66) or age-associated
hypomethylation of genomic DNA (67).
Overall, our data suggest that L1-induced damage to
cells is not conﬁned to germ line and it is likely not
limited to fully active elements. In addition, there is a
potential for the tissue-speciﬁc variation in the L1-
associated damage depending on the spectrum of the
L1-related molecules supported by individual cell types.
Our observations combined with the reported variation
of the combined L1 activity in the population (68) create
the need to reevaluate the potential impact of many of the
full-length L1 elements present in the human genome on
the human health. Further studies providing a more com-
prehensive analysis of potential variation in somatic L1
expression among individuals in population will be
helpful in ascertaining the impact of these elements on
human health.
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